Publications by authors named "Shahrzad Moghim"
Background: Ivabradine has been identified as a funny current (If) inhibitor in the sinoatrial node (SAN) and is considered an advocated therapeutic agent in chronic heart failure and stable angina. This therapeutic agent has shown positive benefits in maintaining a reduction in heart rate while sustaining hemodynamic stability. Its clinical application is still evolving and the mechanism of action is becoming clearer daily.
View Article and Find Full Text PDFArticle Synopsis
- Doxorubicin is an effective cancer treatment but can be toxic to healthy cells, raising concerns about side effects.
- Azithromycin is not only an antibiotic but also has anti-inflammatory properties, yet its protective effects against cellular damage caused by doxorubicin have not been thoroughly investigated.
- In a study using normal human bronchial cells, azithromycin showed potential protective benefits against doxorubicin-induced toxicity by reducing oxidative stress and DNA damage.